| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 60,667 | 65,455 | 63,110 | 56,035 | | Cost of Revenue | 53,820 | 58,500 | 55,682 | 43,441 | | | Gross Profit | 6,847 | 6,955 | 7,428 | 12,594 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,016 | 3,187 | 3,214 | 3,740 | | Non Recurring |
-
|
-
|
-
| 1,188 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,831 | 3,768 | 4,214 | 7,666 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14 | 24 | 51 | 210 | | Earnings Before Interest And Taxes | 3,170 | 4,200 | 4,875 | 8,742 | | Interest Expense | 41 | 52 | 62 | 74 | | Income Before Tax | 3,129 | 4,148 | 4,813 | 8,668 | | Income Tax Expense | 1,166 | 1,463 | 1,846 | 3,634 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,306 | 2,685 | 2,967 | 5,034 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,963 | 2,685 | 2,967 | 5,034 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,963 | $2,685 | $2,967 | $5,034 |
|
0.03% Nasdaq 
Income Statement
